Global POC HbA1C Testing Market Growth (Status and Outlook) 2025-2031

The global POC HbA1C Testing market size is predicted to grow from US$ 580 million in 2025 to US$ 980 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031.

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. HbA1c is your average blood glucose (sugar) levels for the last two to three months. The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels. In this report, we mainly study the devices for POC HbA1C Testing without services.

Market Drivers:

The growing prevalence of diabetes worldwide is a key driver for the POC HbA1c testing market. As the number of diabetic and prediabetic patients continues to rise, there is an increasing need for quick and efficient monitoring solutions to manage blood sugar levels effectively. POC HbA1c testing provides immediate results, allowing for real-time clinical decision-making and reducing patient dependence on centralized laboratories. Additionally, advancements in technology have led to the development of highly accurate, portable, and user-friendly devices, expanding their adoption in hospitals, clinics, and even home settings. Government initiatives promoting early diabetes detection and personalized treatment plans further boost market growth.

Market Challenges:

Despite its advantages, POC HbA1c testing faces several challenges, including high costs and reimbursement limitations in some healthcare systems, which may hinder widespread adoption. Additionally, variations in accuracy and standardization among different POC devices pose concerns regarding result reliability, especially when compared to laboratory-based testing. Regulatory approvals and compliance with stringent quality standards also create barriers for manufacturers entering new markets. Furthermore, lack of awareness and limited access to POC testing in certain developing regions restricts its potential reach, requiring further investments in education and healthcare infrastructure.

LPI (LP Information)' newest research report, the “POC HbA1C Testing Industry Forecast” looks at past sales and reviews total world POC HbA1C Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected POC HbA1C Testing sales for 2025 through 2031. With POC HbA1C Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world POC HbA1C Testing industry.

This Insight Report provides a comprehensive analysis of the global POC HbA1C Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on POC HbA1C Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global POC HbA1C Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for POC HbA1C Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global POC HbA1C Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of POC HbA1C Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Immunoassay
Boronate Affinity
Others

Segmentation by Application:
Hospital and Clinics
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Siemens Healthineers
Roche
Bio-Rad
GREEN CROSS MEDIS
Trinity Biotech
HUMAN Diagnostics
Sinocare (PTS Diagnostics)
Erba Diagnostics
EKF Diagnostics
OSANG Healthcare
SD Biosensor
Aidian
Boditech Med
i-SENS

Please note: The report will take approximately 2 business days to prepare and deliver.